Modeling bile duct ischemia and reoxygenation injury in human cholangiocyte organoids for screening of novel cholangio-protective agents

Medicine and Dentistry

• Alpha 1 Antitrypsin 20%
• Assessment 20%
• Bile Duct 40%
• Bile Duct Disease 40%
• Cell Proliferation 20%
• Chemotherapeutic Agent 20%
• Cholangiocyte 80%
• Combination Therapy 20%
• Drug 20%
• Health 20%
• In Vitro 60%
• Injury 20%
• Inpatient 20%
• Ischemia 100%
• Life 20%
• Liver Disease 20%
• Liver Transplantation 40%
• Marker 20%
• Morbidity 20%
• Mortality 20%
• Necroptosis 20%
• Organoid 80%
• Oxygen 20%
• Pathogenesis 20%
• Programmed Cell Death 40%
• Protective Agent 20%
• Regenerative Medicine 20%
• Screening 20%
• Tenidap 20%
• Upregulation 20%

Biochemistry, Genetics and Molecular Biology

• Apoptosis 20%
• Cell Death 20%
• Cell Proliferation 20%
• Cholangiocyte 80%
• Dynamics 20%
• Health 20%
• Life 20%
• Morbidity 20%
• Mortality 20%
• Necroptosis 20%
• Reoxygenation 60%
• Reperfusion 20%
• Screening 20%
• Upregulation 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Alpha 1 Antitrypsin 20%
• Bile Duct Disease 40%
• Drug 20%
• Injury 20%
• Ischemia 100%
• Liver Disease 20%
• Morbidity 20%
• Mortality 20%
• Oxygen 20%
• Pathogenesis 20%
• Tenidap 20%